TAM inhibitor 2 is primarily used in cancer research and therapy development. It targets TAM receptors (Tyro3, Axl, and MerTK), which are often overexpressed in various cancers, contributing to tumor growth, metastasis, and drug resistance. By inhibiting these receptors, TAM inhibitor 2 can potentially suppress tumor progression and enhance the efficacy of existing treatments like chemotherapy and immunotherapy. It is also studied for its role in modulating the tumor microenvironment, particularly in reducing immune evasion mechanisms employed by cancer cells. Additionally, it shows promise in addressing inflammatory diseases and autoimmune conditions due to its ability to regulate immune responses.